Immatics combines the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors with the goal of enabling a robust and specific T cell response against these targets.
Coriolis Pharma
2 followers
Bayer
504 followers
Boehringer Ingelheim
158 followers
Sandoz
46 followers
Stada Group
17 followers
Azurity Pharmaceuticals
7 followers
Crinetics Pharmaceuticals
6 followers
SmithRx
6 followers
Xeris Pharmaceuticals
5 followers
Orca Bio
4 followers
1Komma5°
12 followers
Clinical Ink
3 followers